[HTML][HTML] Immune imbalances in non-alcoholic fatty liver disease: from general biomarkers and neutrophils to interleukin-17 axis activation and new therapeutic targets
FC Paquissi - Frontiers in immunology, 2016 - frontiersin.org
Non-alcoholic fatty liver disease (NAFLD) is an increasing problem worldwide and is
associated with negative outcomes such as cirrhosis, hepatocellular carcinoma, insulin …
associated with negative outcomes such as cirrhosis, hepatocellular carcinoma, insulin …
Immune Imbalances in Non-Alcoholic Fatty Liver Disease: From General Biomarkers and Neutrophils to Interleukin-17 Axis Activation and New Therapeutic Targets
FC Paquissi - Frontiers in immunology, 2016 - pubmed.ncbi.nlm.nih.gov
Non-alcoholic fatty liver disease (NAFLD) is an increasing problem worldwide and is
associated with negative outcomes such as cirrhosis, hepatocellular carcinoma, insulin …
associated with negative outcomes such as cirrhosis, hepatocellular carcinoma, insulin …
[引用][C] Immune Imbalances in Non-Alcoholic Fatty Liver Disease: From General Biomarkers and Neutrophils to Interleukin-17 Axis Activation and New Therapeutic …
FC Paquissi - Frontiers in Immunology, 2016 - cir.nii.ac.jp
Immune Imbalances in Non-Alcoholic Fatty Liver Disease: From General Biomarkers and
Neutrophils to Interleukin-17 Axis Activation and New Therapeutic Targets | CiNii Research …
Neutrophils to Interleukin-17 Axis Activation and New Therapeutic Targets | CiNii Research …
Immune Imbalances in Non-Alcoholic Fatty Liver Disease: From General Biomarkers and Neutrophils to Interleukin-17 Axis Activation and New Therapeutic Targets.
FC Paquissi - Frontiers in Immunology, 2016 - europepmc.org
Non-alcoholic fatty liver disease (NAFLD) is an increasing problem worldwide and is
associated with negative outcomes such as cirrhosis, hepatocellular carcinoma, insulin …
associated with negative outcomes such as cirrhosis, hepatocellular carcinoma, insulin …
[PDF][PDF] immune imbalances in Non-Alcoholic Fatty Liver Disease: From General Biomarkers and Neutrophils to interleukin-17 Axis Activation and New Therapeutic …
FC Paquissi - Frontiers in Immunology, 2016 - academia.edu
Non-alcoholic fatty liver disease (NAFLD) is an increasing problem worldwide and is
associated with negative outcomes such as cirrhosis, hepatocellular carcinoma, insulin …
associated with negative outcomes such as cirrhosis, hepatocellular carcinoma, insulin …
[PDF][PDF] immune imbalances in Non-Alcoholi c Fatty Liver Disease: From General Biomarkers and Neutrophils to interleukin-17 Axis Activation and New Therapeutic …
FC Paquissi - Frontiers in Immunology, 2016 - researchgate.net
Non-alcoholic fatty liver disease (NAFLD) is an increasing problem worldwide and is
associated with negative outcomes such as cirrhosis, hepatocellular carcinoma, insulin …
associated with negative outcomes such as cirrhosis, hepatocellular carcinoma, insulin …
[HTML][HTML] Immune Imbalances in Non-Alcoholic Fatty Liver Disease: From General Biomarkers and Neutrophils to Interleukin-17 Axis Activation and New Therapeutic …
FC Paquissi - Frontiers in Immunology, 2016 - ncbi.nlm.nih.gov
Non-alcoholic fatty liver disease (NAFLD) is an increasing problem worldwide and is
associated with negative outcomes such as cirrhosis, hepatocellular carcinoma, insulin …
associated with negative outcomes such as cirrhosis, hepatocellular carcinoma, insulin …
[PDF][PDF] immune imbalances in Non-Alcoholi c Fatty Liver Disease: From General Biomarkers and Neutrophils to interleukin-17 Axis Activation and New Therapeutic …
FC Paquissi - Frontiers in Immunology, 2016 - core.ac.uk
Non-alcoholic fatty liver disease (NAFLD) is an increasing problem worldwide and is
associated with negative outcomes such as cirrhosis, hepatocellular carcinoma, insulin …
associated with negative outcomes such as cirrhosis, hepatocellular carcinoma, insulin …
Immune Imbalances in Non-Alcoholic Fatty Liver Disease: From General Biomarkers and Neutrophils to Interleukin-17 Axis Activation and New Therapeutic Targets.
FC Paquissi - Frontiers in Immunology, 2016 - europepmc.org
Non-alcoholic fatty liver disease (NAFLD) is an increasing problem worldwide and is
associated with negative outcomes such as cirrhosis, hepatocellular carcinoma, insulin …
associated with negative outcomes such as cirrhosis, hepatocellular carcinoma, insulin …